Skip to main content

Table 2 Demographic and clinical data

From: Retrospective agreement and consent to neurocritical care is influenced by functional outcome

  All Ischemia ICH SAH Meningoencephalitis Epilepsy GBS/MG Neurodeg./
Enceph.
Cerebral neoplasm Intox.
n (%) 704 241 (34.2) 205 (29.1) 37 (5.3) 47 (67) 86 (12.2) 24 (3.4) 20 (2.8) 19 (2.7) 25 (3.6)
Age (median, range) 67 (18-95) 72 (21-93) 70 (35-95) 56 (19-84) 63 (27-85) 59 (18-93) 58 (23-78) 66 (23-85) 65 (39-78) 53 (29-78)
Female sex (n, %) 328 (46.6) 107 (44.4) 95 (46.3) 19 (51.4) 24 (51.1) 42 (48.8) 13 (54.2) 13 (65.0) 7 (36.8) 8 (32.0)
Mechanical ventilation (n, %) 447 (63.5) 143 (59.3) 141 (68.8) 20 (54.1) 40 (85.1) 44 (51.2) 15 (62.5) 17 (85.0) 7 (36.8) 20 (80.0)
Preadmission
mRS 0-2 (n, %)
628 (89.2) 226 (93.7) 180 (87.8) 34 (91.9) 42 (89.4) 63 (73.3) 23 (95.8) 9 (45.0) 6 (31.6) 45 (96.0)
Consent of all patients (n, %) 361 (51.3) 98 (40.7) 76 (37.1) 23 (62.1) 38 (80.9) 62 (72.1) 19 (79.2) 11 (55.0) 14 (73.7) 20 (80.0)
Satisfaction (n, %) 643 (91.3) 224 (92.9) 195 (95.1) 35 (94.6) 45 (95.7) 65 (75.6) 22 (91.7) 18 (90.0) 16 (84.2) 23 (92.0)
  1. Demographic and clinical characteristics as well as overall consent and satisfaction of all patients (n = 704) separated for diagnoses.
  2. ICH, Intracranial hemorrhage; SAH, subarachnoid hemorrhage; GBS, Guillain-Barré syndrome; MG, myasthenia gravis; Neurodeg, neurodegenerative disease; Enceph, encephalopathy; Intox, intoxication; n, number; mRS, modified Rankin Scale.